British American Tobacco e-cigarette wins UK medicine licence – The Guardian

Posted January 5th, 2016 in health, licensing, medicines, news, smoking by sally

‘Britain’s drug regulators have given the go-ahead for a British American Tobacco (BAT) e-cigarette to be sold as a medicine for quitting smoking, the first such product to be given a drug licence in the UK.’

Full story

The Guardian, 4th January 2016

Source: www.guardian.co.uk

The Importance of Keeping Promises: Warner-Lambert Company LLC v Sandoz GmbH and Others – NIPC Law

Posted December 15th, 2015 in appeals, medicines, news, patents, restraining orders by sally

‘In Swiss Style Claims: Warner-Lambert Companv Actavis 25 Jan 2015 I explained that Warner-Lambert LLC had a patent for a drug called pregabalin for treating epilepsy and GAD (generalized anxiety disorder). That patent expired in 2013 although the monopoly was extended for a short time by a supplementary protection certificate which has now lapsed. Warner-Lambert discovered a new use for pregabalin in the treatment of neuropathic pain for which it was granted a new patent. Actavis sought the revocation of the new patent on grounds of obviousness and insufficiency and applied for permission to market pregabalin for the treatment of epilepsy and GAD. The case that I discussed in my case note was an unsuccessful attempt by Warner-Lambert to impose conditions on the sale of pregabilin in the UK (see Warner -Lambert Company, LLC v Actavis Group Ptc EHF and others [2015] EWHC 72 (Pat)).’

Full story

NIPC Law, 9th December 2015

Source: www.nipclaw.blogspot.co.uk

Nurofen makers under investigation after court rules on misleading adverts – The Guardian

Posted December 15th, 2015 in advertising, complaints, medicines, news by sally

‘The UK’s advertising watchdog is investigating claims made by the makers of Nurofen after an Australian court ordered the company to step selling several versions of the popular painkiller.’

Full story

The Guardian, 15th December 2015

Source: www.guardian.co.uk

Parents’ wish to treat child’s cancer with Chinese medicine overruled by Family Court – UK Human Rights Blog

‘JM (a child), Re [2015] EWHC 2832 (Fam), 7 October 2015. Mostyn J, ruling in the Family Division that a child should receive surgical treatment for bone cancer against the wishes of his parents, has referred to Ian McEwan’s “excellent” novel The Children Act (Jonathan Cape 2014), which is about a 17 year old Jehovah’s Witness refusing a blood transfusion. The judge noted however that the book was in fact “incorrectly titled.” ‘

Full story

UK Human Rights Blog, 11th October 2015

Source: www.ukhumanrightsblog.com

Ex-UN consultants jailed for bribes over drugs supplied to ‘starving Africans’ – The Guardian

Posted September 24th, 2015 in bribery, contracts, corruption, medicines, news, sentencing by tracey

‘Two former UN consultants have been jailed by a UK court for receiving bribes to rig contracts worth £66m to supply life-saving drugs to the Democratic Republic of Congo. Guido Bakker, 41, and Sijbrandus Scheffer, 63, took payments totalling £650,000 from a Danish pharmaceutical company called Missionpharma in return for helping them win lucrative contracts.’

Full story

The Guardian, 23rd September 2015

Source: www.guardian.co.uk

The Pregabalin Trial: Generics (UK) Ltd v Warner-Lambert Company LLC – NIPC Law

Posted September 22nd, 2015 in injunctions, medicines, news, patents by sally

‘According to drugs.com, pregabalin is an anti-epileptic drug which works by slowing down impulses in the brain that cause seizures. A European patent for the drug was granted to Warner-Lambert Co, LLC (“Warner-Lambert”)(now a subsidiary of Pfizer Inc.) under EP number 0 641 330. That patent expired on 17 May 2013 but was extended by a supplementary protection certificate (“SPC”) until 17 May 2018. That SPC was allowed to lapse on 14 Oct 2013 and Warner-Lambert’s data exclusivity in respect of the data used to obtain the marketing authorisation for prehabalin expired on 8 July 2014. Since then anybody has been free to make, import or sell pregabalin for treating epilepsy and generalized anxiety disorder in the United Kingdom and several companies including some of the parties to these proceedings have done just that.’

Full story

NIPC Law, 18th September 2015

Source: www.nipclaw.blogspot.co.uk

Drug promotions and endorsements on social media – the Kim Kardashian case – OUT-LAW.com

Posted August 17th, 2015 in advertising, internet, medicines, news by sally

‘FOCUS: The recent rebuke handed to a drugs manufacturer by a US regulator over the endorsement of its product by celebrity Kim Kardashian highlights differences in the way the direct marketing of prescription medicines is regulated in the US and UK.’

Full story

OUT-LAW.com, 13th August 2015

Source: www.out-law.com

Legal highs a factor in prison deaths, says ombudsman – The Guardian

Posted July 7th, 2015 in drug abuse, medicines, news, prisons, reports, suicide by sally

‘Legal highs are suspected to have been a factor in 19 self-inflicted deaths in prisons in England and Wales over the past two and a half years, an official investigation has found.’

Full story

The Guardian, 7th July 2015

Source: www.guardian.co.uk

Salt in the wound. How precise words in patent claims can be misleading – Technology Law Update

Posted July 3rd, 2015 in medicines, news, patents by tracey

‘Patents are powerful tools, but they only bite on the materials or methods described in their claims. Or do they? Two recent appeal decisions show that the monopoly owned by a patent-holder can spill out over the edges of the claims, making life uncertain for those trying to steer a way around them.’

Full story

Technology Law Update, 3rd July 2015

Source: www.technology-law-blog.co.uk

Amanda Young not guilty of Joshua Gafney manslaughter – BBC News

Posted June 15th, 2015 in homicide, medicines, mental health, negligence, news, nurses by sally

‘A nurse who gave a patient a lethal overdose of a prescription drug has been found not guilty of manslaughter by gross negligence.’

Full story

BBC News, 15th June 2015

Source: www.bbc.co.uk

Thalidomide survivors seek ‘justice’ with Plaid Euro MP – BBC News

Posted June 2nd, 2015 in birth, compensation, disabled persons, health, medicines, news by sally

‘Welsh people left disabled by the thalidomide drug scandal are being backed in their fight for compensation by Plaid Cymru MEP Jill Evans.’

Full story

BBC News, 31st May 2015

Source: www.bbc.co.uk

New pharmacy rules ‘should reduce dispensing mistakes’ – BBC News

Posted May 26th, 2015 in consultations, health, medicines, mistake, news, pharmacists by sally

‘Health ministers want to introduce an airline-style error reporting system for the UK’s high street pharmacies.’

Full story

BBC News, 24th May 2015

Source: www.bbc.co.uk

Fake Viagra gang members sentenced for ‘large-scale criminal enterprise’ – The Guardian

Posted April 14th, 2015 in conspiracy, counterfeiting, gangs, medicines, money laundering, news, sentencing by sally

‘Members of a gang that made up to £60,000 a week selling fake Viagra through a bogus mail order fishing tackle business have been sentenced for their part in what was described by a judge as a “highly organised, large-scale criminal enterprise”.’

Full story

The Guardian, 13th April 2015

Source: www.guardian.co.uk

Yarl’s Wood migrant ‘can sue government over prescribed drug’ – BBC News

‘A migrant who claims her psychosis was triggered by medication given to her at Yarl’s Wood Immigration Removal Centre is to be allowed to sue the government.’

Full story

BBC News, 1st April 2015

Source: www.bbc.co.uk

The new drug-driving offence – Park Square Barristers

‘For many years, there has been a prescribed limit to the amount of alcohol one may have in one’s system when driving, but there has been no parallel legislation or specified limit in relation to drug-driving, prescribed or otherwise.’

Full story

Park Square Barristers, 24th February 2015

Source: www.parksquarebarristers.co.uk

Branded drugs and over-stickering: when is 8.62% a substantial part? – Technology Law Update

‘A brand-owner generally wants to use the same brand across several countries, but there are industries where national branding is common. Pharmaceuticals is one. In a free trade bloc like the EU this leads to a tension between the free movement of goods and protection of IP rights. The interplay of the EU rules in this area has come under the spotlight in SEP v Doncaster.’

Full story

Technology Law Update, 6th March 2015

Source: www.technology-law-blog.co.uk

Legal highs and prescription drugs face ban in English and Welsh prisons – The Guardian

Posted January 27th, 2015 in bills, drug abuse, medicines, news, prisons by sally

‘The justice secretary will be able to ban any legal drug inside prisons, including prescription drugs and “legal highs”, under a crackdown to start this week.’

Full story

The Guardian, 26th January 2015

Source: www.guardian.co.uk

Further appeal against European Commission ‘pay for delay’ patent settlement decision – Zenith Chambers

Posted January 6th, 2015 in appeals, delay, EC law, medicines, news, patents by sally

‘The European Commission’s controversial infringement decision relating to ‘pay for delay’ pharmaceutical patent settlements is subject to a further challenge.’

Full story

Zenith Chambers, 23rd December 2014

Source: www.zenithchambers.co.uk

‘Angel of Death’ murders: TV investigation casts doubt over conviction of Colin Norris – Daily Telegraph

‘New scientific evidence casts fresh doubt on the conviction of a nurse who was jailed for a minimum of 30 years for murdering four elderly women and attempting to kill another, according a TV investigation.’

Full story

Daily Telegraph, 15th December 2014

Source: www.telegraph.co.uk

‘Selection’ patents invalid unless they make ‘plausible’ technical contribution, rules High Court – OUT-LAW.com

Posted December 8th, 2014 in medicines, news, patents by sally

‘Pharmaceutical companies stand to lose patent monopolies that cover a number of individual compounds within a broader chemical formula if they cannot show a plausible link between the compounds covered by the patent and a technical contribution to treatment claimed in the patent, the High Court has confirmed.’

Full story

OUT-LAW.com, 4th December 2014

Source: www.out-law.com